Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/07/1994 | US5318890 Assays for inhibitors of leukocyte adhesion |
06/01/1994 | EP0599822A2 Method of preparation and use for zona pellucida antigens for sterilization and contraception |
06/01/1994 | EP0599338A2 Method for detecting target nucleic acid |
06/01/1994 | EP0599274A1 HER4, a human receptor tyrosine kinase of the epidermal growth factor receptor family |
06/01/1994 | EP0599077A2 Anti-metastatic vaccine |
06/01/1994 | EP0598998A2 Humanized antibodies reacting with the ganglioside GM2 |
06/01/1994 | EP0598935A1 Expression vectors and their use to produce HIV-resistant human cells for therapeutic use |
06/01/1994 | EP0598840A1 Human calcium channel compositions and methods |
06/01/1994 | EP0598832A1 Dna sequencing with a t7-type gene 6 exonuclease |
06/01/1994 | EP0598816A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
06/01/1994 | EP0598806A1 Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants |
06/01/1994 | EP0598792A1 Osteoclast growth regulatory factor |
06/01/1994 | EP0598776A1 Cell lines for assaying human interchromosomal recombination |
06/01/1994 | EP0598768A1 Nucleotide sequences coding for ribosome inactivating proteins |
06/01/1994 | EP0598759A1 Recombinant infectious bovine rhinotracheitis virus |
06/01/1994 | EP0479912B1 Inhibition of the n-end rule pathway in living cells |
06/01/1994 | EP0439458B1 Characterization and detection of sequences associated with autoimmune diseases |
06/01/1994 | EP0200767B1 Sandwich immunoassay of antigens involved in ophthalmic disorders |
06/01/1994 | EP0172865B2 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
06/01/1994 | DE4239817A1 New protein tyrosine kinase and related nucleic acid - vectors, transformed cells, etc., useful for diagnosis and treatment of tumours |
06/01/1994 | DE4228458A1 Multicistronische Expressionseinheiten und deren Verwendung Multicistronic expression units and their use |
06/01/1994 | CN1024809C Microorganism having low acetate forming capability and process for production of useful substrate using same |
05/31/1994 | US5317097 DNA oligomers and genetic engineering |
05/31/1994 | US5317096 Transformation vectors allowing expression of foreign polypeptide endotoxins from Bacillus thuringiensis in plants |
05/31/1994 | US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega |
05/31/1994 | US5317085 Polypeptides for genetic engineering |
05/31/1994 | US5317011 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
05/31/1994 | US5317009 Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
05/31/1994 | US5316947 Synthetic isohirudins with improved stability |
05/31/1994 | US5316946 DNA sequences and cloning for genetic engineering and mutagenesis |
05/31/1994 | US5316935 Subtilisin variants suitable for hydrolysis and synthesis in organic media |
05/31/1994 | US5316934 Prourokinase mutein fused with oligopeptides and fibrin for DNA segments |
05/31/1994 | US5316933 Recombinant natural killer cell activator |
05/31/1994 | US5316931 Genetic engineering |
05/31/1994 | US5316930 DNA molecules and plant or bacteria cells |
05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
05/31/1994 | US5316923 Synthetic yeast leader peptides |
05/31/1994 | US5316922 Binding proteins, ligation polynucleotides and insertion gene coding |
05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
05/31/1994 | US5316919 Genetic engineering; vasodialtors, hypotensive and bronchodilator agents |
05/31/1994 | US5316910 Bioassay for influenza A and B nucleoprotein |
05/28/1994 | CA2110141A1 Oligonucleotides of hcv, primers and probes therefrom, method of determining hcv genotypes, and method of detecting hcv in samples |
05/26/1994 | WO1994011837A1 Oligoprobe designstations: a computerized method for designing optimal oligonucleotide probes and primers |
05/26/1994 | WO1994011738A1 Determination of peptide motifs on mhc molecules |
05/26/1994 | WO1994011535A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
05/26/1994 | WO1994011534A1 Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers which comprise pyrimidine analogs |
05/26/1994 | WO1994011531A1 Identification of neoplasms by detection of genetic insertions and deletions |
05/26/1994 | WO1994011530A1 Positional sequencing by hybridization |
05/26/1994 | WO1994011529A1 A method of processing nucleic acid samples |
05/26/1994 | WO1994011525A1 Improved recombinant production of proteins having factor viii:c activity |
05/26/1994 | WO1994011524A1 Targetable vector particles |
05/26/1994 | WO1994011523A2 Fully impaired consensus kozac sequences for mammalian expression |
05/26/1994 | WO1994011522A2 Vector for the expression of therapy-relevant genes |
05/26/1994 | WO1994011521A1 Bovine heat shock promoter and uses thereof |
05/26/1994 | WO1994011520A2 Novel plants and processes for obtaining them |
05/26/1994 | WO1994011519A1 Production of polyhydroxyalkanoate in plants |
05/26/1994 | WO1994011518A2 Methods for converting a, ab, and b blood types to o blood type |
05/26/1994 | WO1994011517A1 Process for producing l-threonine by fermentation |
05/26/1994 | WO1994011516A1 Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants |
05/26/1994 | WO1994011515A1 Riboflavin synthesis in yeast |
05/26/1994 | WO1994011514A1 Human endogenous retrovirus-k-envelope-gene encoded glycoprotein, and a monoclonal antibody for diagnostic and therapeutic purposes |
05/26/1994 | WO1994011513A1 Heat shock proteins and the treatment of tumours |
05/26/1994 | WO1994011512A2 Allergenic proteins and peptides from japanese cedar pollen |
05/26/1994 | WO1994011511A1 Biocidal chitin binding proteins |
05/26/1994 | WO1994011510A2 Modulators of hematopoietic progenitor cells |
05/26/1994 | WO1994011509A2 Peptides and anti-sense peptides with broad neoplastic specificity |
05/26/1994 | WO1994011508A2 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
05/26/1994 | WO1994011507A2 Production of monoclonal recombinant antibodies without the use of hybridomas by in vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna |
05/26/1994 | WO1994011506A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
05/26/1994 | WO1994011505A1 Pars planitis specific polypeptides |
05/26/1994 | WO1994011504A1 C-c ckr-1, c-c chemokine receptor |
05/26/1994 | WO1994011503A2 Chimeric factor viii |
05/26/1994 | WO1994011502A2 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
05/26/1994 | WO1994011501A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
05/26/1994 | WO1994011500A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
05/26/1994 | WO1994011499A1 Flk-1 is a receptor for vascular endothelial growth factor |
05/26/1994 | WO1994011496A1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
05/26/1994 | WO1994011494A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen |
05/26/1994 | WO1994011402A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
05/26/1994 | WO1994011384A1 Novel cytokine designated elk ligand |
05/26/1994 | WO1994011383A1 A representational approach to dna analysis |
05/26/1994 | WO1994011305A1 Separation of nucleic acid fragments |
05/26/1994 | WO1994011029A1 Human tissue factor related dna segments, polypeptides and antibodies |
05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
05/26/1994 | WO1994011024A1 Composition protective against p. multocida pasteurellosis infection |
05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
05/26/1994 | WO1994011020A1 Eck receptor ligands |
05/26/1994 | WO1994011019A1 Materials and methods for immunocontraception |
05/26/1994 | WO1994011011A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
05/26/1994 | WO1994010831A1 Induction of dwarfing and early flowering using group 3 lea proteins |
05/26/1994 | WO1994009134A3 Modified ciliary neurotrophic factors |
05/26/1994 | WO1994009129A3 Method of cleaving specific strands of rna |
05/26/1994 | WO1994008002A3 Methods and compositions for controlling translation of hcv proteins |
05/26/1994 | WO1994006909A3 A method of preventing tumor metastasis |
05/26/1994 | WO1994002510A3 Analogs of pth |
05/26/1994 | WO1994001558A3 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
05/26/1994 | DE4238904A1 Riboflavin-Synthese in Hefen Riboflavin synthesis in yeasts |
05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
05/26/1994 | CA2572535A1 Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants |
05/26/1994 | CA2149771A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |